<DOC>
	<DOCNO>NCT01286051</DOCNO>
	<brief_summary>Ovulation induction ( OI ) use gonadotropins one widely prescribed treatment infertility . One common problem encounter attempt OI use gonadotropin premature ovulation . The purpose study examine effect single injection medication , call ganirelix , prevent premature ovulation . Patients divide two group . In first group , gonadotropin use stimulate ovary . In second group gonadotropin use addition single injection ganirelix , gonadotropin release hormone ( GnRH ) antagonist . Pregnancy rate compare group .</brief_summary>
	<brief_title>Single Injection Ganirelix Gonadotropin Intrauterine Insemination ( IUI ) Cycles</brief_title>
	<detailed_description>A randomized prospective study perform patient attempt pregnancy use ovulation induction/intra-uterine insemination ( IUI ) . Patients randomly assign one two protocol : Protocol A ( control group ) : On menstrual cycle day 3 , patient start gonadotropin ( Follistim ) injection start dose 75-150 IU monitor accord discretion treat physician . When lead follicle reach size least 18mm , intramuscular human chorionic gonadotripin ( hCG ) ( 10,000 IU ) administer , follow two insemination , one 12 hour hCG , 36 hour . All patient luteal support use progesterone vaginal suppository dose 200mg two time per day ( BID ) . Pregnancy test schedule 2 week IUI . The treatment cycle typically last 8-13 day , depend patient 's response . Protocol B ( study group ) : On menstrual cycle day 3 , patient start gonadotropin ( Follistim ) injection start dose 75-150 IU monitor accord discretion treat physician . When lead follicle reach size 13-14mm mean diameter , estradiol level reach level 400 pg/ml , ganirelix injection standard dose 250mcg give subcutaneously . When lead follicle reach size least 18mm , intramuscular hCG ( 10,000IU ) administer follow two insemination , one 12 hour hCG , 36 hour . All patient luteal support use progesterone suppository dose 200mg BID . Pregnancy test schedule 2 week IUI . The treatment cycle typically last 8-13 day , depend patient 's response . Patients randomize , via computer generate program , 1:1 fashion .</detailed_description>
	<mesh_term>Ganirelix</mesh_term>
	<criteria>Patients undergo ovulation induction ( OI ) age 18 39 year . One follow infertility diagnosis : ovulation dysfunction , mild male factor infertility ( sperm concentration 5 20 million/ml , and/or sperm motility 10 % 40 % ) , absence teratospermia ( i.e . strict morphology &gt; 4 % ) , unexplained infertility . Patent Fallopian tube . Normal uterine structure ( i.e . absence mullerian anomaly ) Ability consent study . Patients Houston Fertility Institute patient Exclusion criterion include : Age 39 Severe male factor ( concentration &lt; 10 million/ml strict morphology &lt; 4 % ) Obstructed Fallopian tube one side Stage III IV endometriosis Elevated FSH level ( &gt; 10 IU/L ) Low antral follicular count ( &lt; 4 antral follicle per ovary ) Any contraindication ovulation induction Inability consent study History prior fail OI/IUI cycle</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>ovulation induction , GnRH</keyword>
</DOC>